Classification of accelerated phase chronic myeloid leukemia in the era of the BCR::ABL1 tyrosine kinase inhibitors: A work in progress

被引：11

作者：

Kantarjian, Hagop M. M. ^{[1
]}

Tefferi, Ayalew ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Mayo Clin, Dept Leukemia, Rochester, MN USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 09期

关键词：

HEALTH-ORGANIZATION; TERMINAL PHASE; THERAPY;

D O I：

10.1002/ajh.27007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1350 / 1353

页数：4

共 24 条

[1] Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial [J].

Apperley, Jane F. ;

Cortes, Jorge E. ;

Kim, Dong-Wook ;

Roy, Lydia ;

Roboz, Gail J. ;

Rosti, Gianantonio ;

Bullorsky, Eduardo O. ;

Abruzzese, Elisabetta ;

Hochhaus, Andreas ;

Heim, Dominik ;

de Souza, Carmino A. ;

Larson, Richard A. ;

Lipton, Jeffrey H. ;

Khoury, H. Jean ;

Kim, Hyeoung-Joon ;

Sillaber, Christian ;

Hughes, Timothy P. ;

Erben, Philipp ;

Van Tornout, Jan ;

Stone, Richard M. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) :3472-3479

[2] International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data [J].

Arber, Daniel A. ;

Orazi, Attilio ;

Hasserjian, Robert P. ;

Borowitz, Michael J. ;

Calvo, Katherine R. ;

Kvasnicka, Hans-Michael ;

Wang, Sa A. ;

Bagg, Adam ;

Barbui, Tiziano ;

Branford, Susan ;

Bueso-Ramos, Carlos E. ;

Cortes, Jorge E. ;

Dal Cin, Paola ;

DiNardo, Courtney D. ;

Dombret, Herve ;

Duncavage, Eric J. ;

Ebert, Benjamin L. ;

Estey, Elihu H. ;

Facchetti, Fabio ;

Foucar, Kathryn ;

Gangat, Naseema ;

Gianelli, Umberto ;

Godley, Lucy A. ;

Gokbuget, Nicola ;

Gotlib, Jason ;

Hellstrom-Lindberg, Eva ;

Hobbs, Gabriela S. ;

Hoffman, Ronald ;

Jabbour, Elias J. ;

Kiladjian, Jean-Jacques ;

Larson, Richard A. ;

Le Beau, Michelle M. ;

Loh, Mignon L. -C. ;

Lowenberg, Bob ;

Macintyre, Elizabeth ;

Malcovati, Luca ;

Mullighan, Charles G. ;

Niemeyer, Charlotte ;

Odenike, Olatoyosi M. ;

Ogawa, Seishi ;

Orfao, Alberto ;

Papaemmanuil, Elli ;

Passamonti, Francesco ;

Porkka, Kimmo ;

Pui, Ching-Hon ;

Radich, Jerald P. ;

Reiter, Andreas ;

Rozman, Maria ;

Rudelius, Martina ;

Savona, Michael R. .

BLOOD, 2022, 140 (11) :1200-1228

[3] European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 [J].

Baccarani, Michele ;

Deininger, Michael W. ;

Rosti, Gianantonio ;

Hochhaus, Andreas ;

Soverini, Simona ;

Apperley, Jane F. ;

Cervantes, Francisco ;

Clark, Richard E. ;

Cortes, Jorge E. ;

Guilhot, Francois ;

Hjorth-Hansen, Henrik ;

Hughes, Timothy P. ;

Kantarjian, Hagop M. ;

Kim, Dong-Wook ;

Larson, Richard A. ;

Lipton, Jeffrey H. ;

Mahon, Francois-Xavier ;

Martinelli, Giovanni ;

Mayer, Jiri ;

Mueller, Martin C. ;

Niederwieser, Dietger ;

Pane, Fabrizio ;

Radich, Jerald P. ;

Rousselot, Philippe ;

Saglio, Giuseppe ;

Saussele, Susanne ;

Schiffer, Charles ;

Silver, Richard ;

Simonsson, Bengt ;

Steegmann, Juan-Luis ;

Goldman, John M. ;

Hehlmann, Ruediger .

BLOOD, 2013, 122 (06) :872-884

[4] Staging of chronic myeloid leukemia in the imatinib era - An evaluation of the World Health Organization proposal [J].

Cortes, JE ;

Talpaz, M ;

O'Brien, S ;

Faderl, S ;

Garcia-Manero, G ;

Ferrajoli, A ;

Verstovsek, S ;

Rios, MB ;

Shan, J ;

Kantarjian, HM .

CANCER, 2006, 106 (06) :1306-1315

[5] High-risk additional chromosomal abnormalities at low blast counts herald death by CML [J].

Hehlmann, Ruediger ;

Voskanyan, Astghik ;

Lauseker, Michael ;

Pfirrmann, Markus ;

Kalmanti, Lida ;

Rinaldetti, Sebastien ;

Kohlbrenner, Katharina ;

Haferlach, Claudia ;

Schlegelberger, Brigitte ;

Fabarius, Alice ;

Seifarth, Wolfgang ;

Spiess, Birgit ;

Wuchter, Patrick ;

Krause, Stefan ;

Kolb, Hans-Jochem ;

Neubauer, Andreas ;

Hossfeld, Dieter K. ;

Nerl, Christoph ;

Gratwohl, Alois ;

Baerlocher, Gabriela M. ;

Burchert, Andreas ;

Bruemmendorf, Tim H. ;

Hasford, Joerg ;

Hochhaus, Andreas ;

Saussele, Susanne ;

Baccarani, Michele .

LEUKEMIA, 2020, 34 (08) :2074-2086

[6] Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia - Comparison with historic experience [J].

Kantarjian, H ;

Talpaz, M ;

O'Brien, S ;

Giles, F ;

Faderl, S ;

Verstovsek, S ;

Garcia-Manero, G ;

Shan, JQ ;

Rios, MB ;

Champlin, R ;

de Lima, M ;

Cortes, J .

CANCER, 2005, 103 (10) :2099-2108

[7]

Kantarjian H., 2022, HARRISONS PRINCIPLES, P818

[8]

Kantarjian H., 1987, J CLIN ONCOL, V5, P1033

[9]

Kantarjian H, 2020, MOLECULAR HEMATOLOGY, 4TH EDITION, P71

[10]

KANTARJIAN HM, 1988, CANCER-AM CANCER SOC, V61, P1441, DOI 10.1002/1097-0142(19880401)61:7<1441::AID-CNCR2820610727>3.0.CO

← 1 2 3 →